Sepsis: developing new alternatives to reduce neuroinflammation and attenuate brain injury
- 1 February 2019
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1437 (1), 43-56
- https://doi.org/10.1111/nyas.13985
Abstract
Sepsis occurs when a systemic infection induces an uncontrolled inflammatory response that results in generalized organ dysfunction. The exacerbated peripheral inflammation can induce, in turn, neuroinflammation which may result in severe impairment of the central nervous system (CNS). Indeed, the ensuing blood-brain barrier disruption associated with sepsis promotes glial activation and starts a storm of proinflammatory cytokines in the CNS that leads to brain dysfunction in sepsis survivors. Endotoxic shock induced in mice by peripheral injection of lipopolysaccharides closely resembles the peripheral and central inflammation observed in sepsis. In this review, we provide an overview of the neuroinflammatory features in sepsis and of recent progress toward the development of new anti-neuroinflammatory therapies seeking to reduce mortality and morbidity in sepsis survivors.Keywords
This publication has 118 references indexed in Scilit:
- Intranasal Treatment of Central Nervous System Dysfunction in HumansPharmaceutical Research, 2012
- Intranasal Delivery of HMGB1 siRNA Confers Target Gene Knockdown and Robust Neuroprotection in the Postischemic BrainMolecular Therapy, 2012
- Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the BrainMolecular Therapy, 2011
- The Parasympathetic Nervous System in the Quest for Stroke TherapeuticsJournal of Cerebral Blood Flow & Metabolism, 2011
- The role of antigen presenting cells in multiple sclerosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe SepsisJAMA, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokinesBrain, Behavior, and Immunity, 2008
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007
- CNS immune privilege: hiding in plain sightImmunological Reviews, 2006